Skip to main content

Address

Panerių g. 246
48454 Kaunas
Lithuania

Opening hours

  • Mon – Fri
    9 :00 – 17 00
  • Sat
    Closed    
  • Sun
    Closed   
Dog DNA testing illustration

Glycogen Storage Disease Ia (GSD1a) – German Pinscher

Code: H188

74,72 €

Sample details

One test – one sample. Animal and owner details are optional.

Search by our number or the laboratory number. An unmatched number is saved as a previous / external reference. No new physical sample is needed.
The add to cart button will appear once you select the values above

Short description

Glycogen Storage Disease Type Ia (also known as GSD1a and von Gierke disease) is a genetic disorder caused by mutations in the Glucose-6-phosphatase (G6PC) gene, leading to issues with glucose metabolism.

General information

Glycogen Storage Disease Type Ia (also known as GSD1a and von Gierke disease) is a genetic disorder caused by mutations in the Glucose-6-phosphatase (G6PC) gene, leading to issues with glucose metabolism. This is due to the inability of the body to release stored glucose from glycogen when needed, leading to inadequate fuel for the body’s energy needs. The variant of this test is an autosomal recessive mutation found in the German Pinscher.

Specifications

Breeds

German Pinscher

Gene

G6PC

Chromosome

9

Mutation

c.634_635insN[76]

Organ

Digestive System

Specimen

Swab, Blood EDTA, Blood Heparin, Semen, Tissue

Mode of Inheritance

Autosomal Recessive

Also known as

GSD la; von Gierke disease

Clinical features

Affected animals can have recurrent episodes of low blood sugar (hypoglycemia), which can display as weakness, tremors, confusion, and in severe cases, seizures or loss of consciousness. In addition accumulation of glycogen can occur in the cells of the liver and kidneys causing an enlarged liver (hepatomegaly) or kidneys (nephromegaly), elevated blood levels of cholesterol and triglycerides, urinary tract stones due to elevated uric acid levels, and potentially distention of the abdomen due to the enlarged liver and/or kidneys. It can also cause delays in growth and development due to the inability to properly metabolize energy. These clinical signs can severely affect the quality of life as they can lead to poor growth, fatigue, pain and urinary tract obstructions (if stones develop in the urinary tract) and muscle weakness.

References

Pubmed ID: 34610166

Year published: 2021

Omia ID: 418

Omia variant ID:

Turnaround information

  • 15 working days